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E-mail address: byang@sri.utoronto.ca (B.B. Yang).We found that nephronectin was signiﬁcantly down-regulated by TGF-b1. To determine the function
of nephronectin in osteogenesis, we generated various constructs to produce stable MC3T3-E1 cell
lines, expressing and secreting nephronectin protein, including full-length (Npnt), lacking EGF-like
repeats (Np-MAM), and lacking RGD andMAM domains (Np-EGF). We demonstrated that nephronec-
tin promotes differentiation during osteoblast differentiation and the EGF-like repeats were essen-
tial. Lack of these repeats resulted in inhibiting the change in morphology. Over-expression of
nephronectin results in earlier formation of bone nodules than the vector control. ERK activation
is essential for nephronectin-induced osteoblast differentiation.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction during fetal calvarial development in vivo [3–6]. Using this system,Nephronectin (Npnt) was detected in the developing mouse
kidney as a novel ligand for the integrin a8b1 [1]. It was a secreted
extracellular matrix (ECM) protein that contains a putative signal
peptide, ﬁve epidermal growth factor (EGF)-like repeats, an RGD
sequence, and a COOH-terminal MAM domain. Since both the
EGF-like repeats and the MAM domain could mediate protein–
protein interactions, nephronectin could interact with various
proteins in the ECM. Previous studies found that nephronectin is
signiﬁcantly down-regulated by TGF-b1 during osteoblast develop-
ment [2].
MC3T3-E1 is an ideal in vitro model system for bone develop-
ment. These cells undergo an ordered, time-dependent develop-
mental sequence characterized by three stages: preosteoblast
proliferation followed by growth arrest, differentiation of preos-
teoblasts into osteoblasts. These stages are analogous to the
respective stages of in vivo bone development. This in vitro system
is biologically relevant because the temporal sequence of ex-
pressed genes encoding the osteoblast phenotype markers in
MC3T3-E1 cells follows the speciﬁc pattern of gene expression
and cell-type distribution observed in neonatal long bones, andchemical Societies. Published by E
l medium; FBS, fetal bovine
t, nephronectin; ALP, alkaline
ealth Sciences Centre, 2075we demonstrated that expression of nephronectin promotes osteo-
blast differentiation via its EGF-repeats.
2. Results and discussion
2.1. Expression of nephronectin during osteogenesis in vivo
Bone matrix contains high concentrations of several growth fac-
tors belonging to the TGF-b superfamily. To understand the conse-
quences of signalling during bone development, we used cDNA
microarray technology to identify TGF-b responsive targets [2].
From the 120 differentially expressed genes, nephronectin was
identiﬁed as one of the genes that was signiﬁcantly down-regu-
lated by TGF-b1 during osteoblast development. Nephronectin, a
novel ligand for the integrin a8b1, was discovered in the develop-
ing mouse kidney [1,7]. We investigated this gene further as it rep-
resents a previously uncharacterized potential target of TGF-b.
RNA was extracted from MC3T3-E1 cells on various days cover-
ing the three different stages of bone development. We found that
nephronectin expression reached the highest levels during the later
stage of proliferation (Fig. 1A, days 5 and 7), followed by a decrease
through the differentiation phase (days 12–20), and was minimal
during the mineralization (days 25–35) phase. We examined neph-
ronectin expression in mouse using whole embryo extracts from
different embryonic gestation days and observed increased expres-
sion with time (Fig. 1B). We detected high levels of nephronectin
mRNA in the kidneys, lung, choroid plexus, tongue, jawbone, dentallsevier B.V. All rights reserved.
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Fig. 1. Nephronectin expression. (A) MC3T3-E1 cells were cultured under nodule-inducing conditions and total RNA was extracted on various days. A total of 10 lg RNA was
analyzed on Northern blot. Top panel shows the nephronectin expression pattern. GAPDH signal for the same blot is shown. (B) A nylon membrane (ClonTech) containing RNA
extracted frommouse embryos on four different days was probed for nephronectin expression. (C) In situ hybridization of nephronectin expression in E15.5. Panel a: negative
control; panel b: high levels of nephronectin mRNA detected in the kidney (k), lungs (l), choroid plexus (cp), tongue (t), jaw bone (jb), dental epithelium (de), facial bones (fb)
and calvaria (c); panel c: a magniﬁed image of the jaw bone demarcated by the square in panel b (b = bone, mc = Meckel’s cartilage). Black arrows indicate areas of strong
mRNA expression in proliferating osteoblasts while the red arrows indicate areas of little or no expression in differentiated osteoblasts. Panel d: a magniﬁed image of the
calvaria from panel b (c = calvaria, br = brain). (D) Total RNA extracted from various tissues of the E15.5 mouse embryos was analyzed for nephronectin expression. (E) Total
RNA extracted from various tissues of the E17.5 mouse embryos was analyzed for nephronectin expression. (F) Using the anti-nephronectin serum, signiﬁcant nephronectin
expression was detected as brown staining in the developing long bone, as compared with the control section that had been exposed to the secondary antibody only.
Expression of nephronectin was detected in the developing kidney, developing tooth, and in the ECM of the developing jawbone.
234 S. Kahai et al. / FEBS Letters 584 (2010) 233–238epithelium, and facial bones of the E15.5 mouse (Fig. 1C). A lower
level of nephronectin was seen in the calvaria, as evident from
themagniﬁed image (Fig. 1C panel d). As seen in themagniﬁed view
of the jawbone (Fig. 1C panel c), there was no nephronectin expres-
sion in Meckel’s cartilage, but a high level of expression was ob-
served in the developing jawbone. Nephronectin expression was
found to be different during the different stages of development
of the jawbone (Fig. 1C panel c). High expression was observed in
the proliferating osteoblasts (indicated by black arrows) while little
or no expression was found in the differentiated osteoblasts (indi-
cated by red arrows). Consistent with these results, we found high
nephronectin expression in the kidney (Fig. 1D).
Expression of nephronectin in the E17.5 embryo was also ana-
lyzed. High levels of nephronectin were observed in the kidney,while much lower level in the calvaria, and no expression was seen
in the liver (Fig. 1E). High nephronectin level was also seen in the
lung, while weak expression was observed in the other tissues
including heart, spleen, intestine and brain. Immunohistochemis-
try showed that signiﬁcant nephronectin in E15.5 was found in
the basement membrane of the developing kidney, in the develop-
ing long bone, in the basement membrane of the developing tooth,
and in the ECM of the developing jawbone (Fig. 1F).
2.2. The EGF-repeat is essential for the promotion of osteoblast
differentiation by nephronectin
To study the role of nephronectin during osteoblast develop-
ment, we expressed the full-length nephronectin in the MC3T3-
S. Kahai et al. / FEBS Letters 584 (2010) 233–238 235E1 cells. Conditioned medium from each stable cell line was exam-
ined (Fig. 2A). Staining for alkaline phosphatase (ALP) expression
showed that the nephronectin-transfected cells produced much
higher levels of ALP than the empty vector (Fig. 2B). To determine
which domain was responsible for promoting osteoblast differenti-
ation, a truncated nephronectin construct, Np-MAM, was gener-
ated (Fig. 2A). Cells expressing Np-MAM produced minimal ALP
levels (Fig. 2C), with a ﬁbroblastic morphology (Fig. S1). These re-
sults suggest that the 5 EGF-like-repeats were essential for osteo-
blast differentiation. A construct containing the EGF-repeats were
generated (Fig. 2A). An extremely high level of ALP was detected
in the cells over-expressing the truncated nephronectin (Np-EGF-
1) compared with the controls (Fig. 2D). The Np-EGF-transfected
cells exhibited a cuboidal morphology (Fig. S2).
2.3. Effect of the EGF-repeats on nodule formation during osteogenesis
We then investigated the role of these constructs in ALP expres-
sion and nodule formation. Cells-transfected with the vector, Npnt,
Np-MAM, and Np-EGF were cultured over the three phases of bone
development. We found that throughout the course of osteogene-
sis, the Np-EGF-transfected cells produced the highest level of ALP,
followed by the cells-expressing Npnt (Figs. 3A and S3). MinimalLP
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Fig. 2. Osteoblast differentiation is enhanced by nephronectin. (A) Upper, a full-length ne
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nephronectin Np-MAM. Another truncated construct containing the ﬁrst four but only par
was analyzed by western blotting to conﬁrm expression and secretion of the protein in
vector-transfected MC3T3-E1 cell lines were grown for 10 days and stained for ALP exp
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The cells were also stained with silver nitrate for visualization
of bone nodules. Multiple nodules were ﬁrst seen in the Np-EGF
cells on day 38 (Fig. 3B). The next cell line to show nodule forma-
tion was nephronectin on day 52, though the number of nodules
was lesser than that in the Np-EGF-transfected cells. On day 52,
no nodules were seen in the vector or in the Np-MAM-transfected
cells. A magniﬁed view in a different phase of the nodules formed
in the Npnt- and Np-EGF-transfected cells, while no nodules were
seen in the vector and Np-MAM-transfected cells (Fig. 3C). There-
fore, these results indicated that nephronectin plays an important
role in osteoblast differentiation, and that its EGF-like repeats were
essential for this process.
2.4. ERK is an important downstream player in nephronectin signalling
Our previous studies indicate that the EGF-like repeats of vers-
ican play important roles in cell proliferation, differentiation, apop-
tosis, and morphogenesis by signalling through the EGFR-ERK
pathway [8–10]. In addition, integrins also modulate adhesion
associated cell differentiation and proliferation [11]. Since nephro-
nectin is a secreted ECM protein known to interact with the inte-MAMRGD
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Fig. 3. Cell differentiation affected by nephronectin domains. (A) The MC3T3-E1 cell lines stably transfected with different nephronectin constructs were cultured under
nodule-inducing conditions. The levels of cell differentiation were Np-EGF > Npnt > vector > Np-MAM. (B) The cells stably transfected with different nephronectin constructs
were cultured for osteoblast development. Silver Nitrate staining of bone nodules was performed during the ﬁnal phase. (C) The representation of the results of panel B in a
different phase showing a micrograph of a magniﬁed image of the bone nodules formed in the different cell lines in a single ﬁeld.
236 S. Kahai et al. / FEBS Letters 584 (2010) 233–238grin a8b1, and since our results indicate that nephronectin expres-
sion was essential for the transition of osteoblasts, we investigated
the ERK/MAPK pathway as a possible mechanism for nephronectin
signalling. We found that the level of phosphorylated ERK was the
lowest in the Np-MAM cells (Fig. 4). The Npnt and Np-EGF cells ex-
pressed higher levels of phosphorylated ERK, which is consistent
with the occurrence of differentiation. In the proteins extracted
after 10 days, the level of phosphorylated ERK was highest in the
Np-EGF cells followed by the Npnt cells, in agreement with their
higher rates of differentiation. The Np-MAM cells exhibited the
lowest level of ERK phosphorylation. Consistent with this is the
lowest level of osteoblast differentiation.
Since the Np-MAM construct does not contain a functional EGF-
repeat, signalling through the EGF-like repeats was inhibited,
thereby leading to extremely low levels of ERK phosphorylation.
Considering the fact that the Np-EGF construct exerted the greatest
activity in the promotion of cell differentiation, and that the neph-
ronectin construct exerted moderate activity in the promotion of
cell differentiation although they contain the ﬁve EGF-like repeats,
we propose that the EGF-like repeats are essential for osteoblast
differentiation and that the RGD and MAM domains play a balanc-
ing role in nephronectin functioning. The exact effects of these two
domains in the inhibition of ERK signalling and cell differentiation
await further investigation.
This is consistent with the differentiation results, and it sug-
gests that increased phospharylation of ERK is essential for nephro-
nectin functioning in cell differentiation. This is consistent withour previous reports that activation of ERK plays an important role
in cell survival and cell differentiation [12,13]. Once again and con-
sistently, the Np-MAM cells exerted the lowest level of ERK phos-
phorylation, in agreement with its effect on cell differentiation.
Taken together, our data suggests that ERK activation is essential
for nephronectin-induced osteoblast differentiation.
3. Methods
3.1. Construct generation
The primers used to generate different nephronectin constructs
are as follows. Npnt-N (50-cccgggctcgagtggcccaggcaaatagtttct) and
Npnt-C (50-ccc ggg tct aga tca gca gcg acc tct ttt caa) were used to
clone nephronectin coding sequence. Npnt-EGF (50-cccgggctc-
gaggtgtatatccccaaagtc) and Npnt-C were used to delete the EGF-re-
peats. A point mutation was obtained by PCR obtaining the EGF
expression construct. A link protein leading peptide (LP) was at-
tached to the N-terminus of each construct to allow product secre-
tion [8] and detection by the monoclonal antibody 4B6.
3.2. RNA isolation and analysis
Total RNA was extracted with Trizol reagent according to the
manufacturer’s instructions (Invitrogen). A total of 5–10 lg RNA
was size fractionated and transferred onto a nylon membrane.
Northern hybridization was conducted with an appropriate probe
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Fig. 4. Effects of nephronectin on ERK expression and ERK phosphorylation. Cell
lysate from various cells lines was prepared from 4 h (A) and 10 day (B) cultures.
The lysate was separated on a 12% SDS–polyacrylamide gel electrophoresis (PAGE)
and analyzed by western blotting for ERK expression of ERK phosphorylation.
Analysis of the expression of b-actin was used as a control to determine equal
loading.
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el intensity was quantiﬁed.
The E15.5 parafﬁn-embedded mouse embryos were sectioned
at a thickness of 10 lm, and RNA in situ hybridization was per-
formed as described [14]. The probes used were single-stranded
RNA of deﬁned length, either in the sense (control) or anti-sense
orientation, generated by in vitro transcription in the presence of
digoxigenin-UTP, using T3 or T7 RNA polymerases. The plasmid
DNA for the preparation of the 900-bp nephronectin probe was
kindly provided by Dr. Reichardt at the University of California.
After overnight hybridization, the probe was incubated with Fab
fragments from an anti-digoxigenin antibody from sheep, conju-
gated with ALP (Roche Biochemicals). Speciﬁcity was provided by
the Fab fragments, which bind only to digoxigenin. Colorimetric
detection of DIG-labeled probes was performed by using two color-
less substrates namely BCIP and NBT.
3.3. Alkaline phosphatase staining
Staining was performed as previously described [2].3.4. Silver nitrate staining (Von Kossa’s method)
Cells were cultured in parallel (seeding density: 2  105 cells/
well) in 6-well plate-, in alpha-minimum essential medium (a-
MEM) supplemented with 10% fetal bovine serum (FBS), antibiot-
ics, 50 lg/mL ascorbic acid, 10 mM beta-glycerolphosphate, and
108 M dexamethasone, over the three different phases of osteo-
blast development. Silver nitrate staining for the detection of bone
nodules was performed on different days. The cells were rinsed
with PBS and ﬁxed with 10% neutral formalin solution for
15 min. After washing with distilled water for 15 min, the cells
were incubated with 2.5% silver nitrate solution (silver nitrate in
water) in the dark for 30 min at room temperature. After a 15-
min wash with distilled water, the silver nitrate stain was devel-
oped with 5% sodium carbonate in 25% formalin for 2–5 min, until
the bone nodules turned black. Finally, the cells were washed over-
night in tap water and the bone nodules were photographed the
next day.
3.5. Western blot
Cells were harvested by 10 mM EDTA at 60–80% conﬂuence and
washed three times with PBS. Lysates were subjected to western
blot analysis as described in detail by us recently [15–17].
3.6. Immunohistochemistry
Immunohistochemistry was performed on MC3T3-E1 cells as
well as on 10 lm thick sections from demineralized parafﬁn-
embedded E15.5 mouse embryos as described previously [2]. The
anti-serum to nephronectin used was a generous gift from Dr.
Louis. F. Reichardt (University of California, San Francisco, USA).
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